Compare Hershey Co (HSY) vs Natera Inc. Common Stock (NTRA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hershey Co vs Natera Inc. Common Stock — how do they compare? Hershey Co trades at $165.99 (market cap $33.00B), while Natera Inc. Common Stock trades at $393.27 (market cap $57.03B). The key difference: Natera Inc. Common Stock is the larger of the two by market cap, and Hershey Co pays a 3.54% dividend while Natera Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Hershey Co for 135 Days and Natera Inc. Common Stock for 0 Days on average.
| HSY | NTRA | |
|---|---|---|
Market Cap | $33.00B | $57.03B |
Volume | 1,157,600 | 1,131,157 |
Sector | Consumer Staples | Health |
52-Week High | $236.28 | $425.64 |
52-Week Low | $157.61 | $179.42 |
Typical Hold Time | 135 Days | 0 Days |
Enterprise Value | $38.13B | $56.18B |
Dividend Yield | 3.54% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hershey (HSY) trades at $163.05, down 0.48% with bearish technical signals including oversold RSI readings. The company shows strong profitability with 38.38% gross margins and 32.81% ROE, though 2025 net income declined to $883 million. Recent earnings beats and a $1.45 dividend payment demonstrate operational strength despite commodity cost pressures.
HSY presents a mixed outlook with analyst consensus target of $203.69 suggesting 25% upside, but technical weakness and margin compression from cocoa costs pose near-term risks. The stock's current valuation at 22.27 P/E appears reasonable for a consumer staple leader with consistent dividend payments and brand strength.
NTRA trades at $395.66, down 0.53% today but remains near recent highs. The stock shows mixed technical signals with neutral momentum indicators. Fundamentally, the company demonstrates strong revenue growth ($2.31B in 2025, projected $2.7B in 2026) but continues to operate at a net loss (-$208M in 2025). Recent positive developments include FDA Breakthrough Device designation for its multi-cancer detection assay and regulatory approval in Japan for Signatera.
NTRA presents a growth story with significant analyst support (89% buy ratings) but carries execution risks. The stock trades at premium valuations (P/S 20.48) while still unprofitable. Key catalysts include clinical trial progress and international expansion, though investors face risks from ongoing losses and competitive pressures in precision medicine.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Hershey Co
Hershey is a leading confectionery manufacturer in the U.S. (around a $25 billion market), controlling around 46% of the domestic chocolate space (per IRI). Beyond its namesake label, the firm's mix has expanded over the last 85 years and now consists of 100 brands, including Reese's, Kit Kat, Kisses, and Ice Breakers. Hershey's products are sold in about 80 countries, albeit with just a high-single-digit percentage of sales coming from markets outside the U.S., including Brazil, India, and Mexico. The firm has sought inorganic opportunities to extend its reach beyond its core confection business, adding Amplify Snack Brands and its Skinny Pop ready-to-eat popcorn to its mix and Pirate Brands (including the Pirate's Booty, Smart Puffs, and Original Tings brands) over the past few years.
Read more on HSY →About Natera Inc. Common Stock
Natera, Inc. develops and provides cell-free DNA-based genetic testing across women's health, oncology, organ health, and rare disease, with flagship products including Panorama for noninvasive prenatal screening and Signatera for cancer recurrence monitoring.
Read more on NTRA →
